The orphan nuclear receptor NR2E3 is a direct transcriptional target of NRL, the key basic motif leucine zipper transcription factor that dictates rod versus cone photoreceptor cell fate in the mammalian retina. The lack of NR2E3 function in humans and in retinal degeneration rd7 mutant mouse leads to increased S-cones accompanied by rod degeneration, whereas ectopic expression of Nr2e3 in the cone-only Nrl -/-retina generates rod-like cells that do not exhibit any visual function. Using GFP to tag the newborn rods and by BrdU birthdating, we demonstrate that early-born post-mitotic photoreceptor precursors in the rd7 retina express cone-specific genes. Transgenic mouse studies in the rd7 background show that Nr2e3 when expressed under the control of Crx promoter can restore rod photoreceptor function and suppress cone gene expression. Furthermore, Nr2e3 expression in photoreceptor precursors committed to be rods (driven by the Nrl promoter) could completely rescue the retinal phenotype of rd7 mice. We conclude that excess of S-cones in the rd7 retina originate from photoreceptor precursors with a "default" fate and not from proliferation of cones and that Nr2e3 is required to suppress the expression of S-cone genes during normal rod differentiation. These studies further support the "transcriptional dominance" model of photoreceptor cell fate determination and provide insights into the pathogenesis of retinal disease phenotypes caused by NR2E3 mutations.
INTRODUCTION
The retina is a highly stratified sensory tissue in the central nervous system. It consists of three cellular layers containing six major types of neurons and one type of glial cell. Two types of photoreceptors (rods and cones) are exclusively located in the outer nuclear layer (ONL); in most mammals, rods greatly outnumber cones, which are primarily distributed along the outer (scleral) side of the ONL (1). Rods are highly photon sensitive and function in low light conditions, whereas cones are responsible for visual acuity and mediate daylight and color vision (2) . Based on differences in visual pigments [called opsins], the human retina has three subtypes of cones (short -S, medium -M, and long -L wave-length) (3, 4) . The mouse retina has only S and M cones, and these are spatially distributed in a ventral to dorsal gradient with a majority expressing both cone opsins (5, 6 ).
In the vertebrate retina, all neurons and Müller glia are generated from pool(s) of multipotent neuroepithelial progenitors with a relatively conserved birth order (7, 8) . In mouse retina, almost all cones are generated between embryonic day 11 (E11) and E16. On the contrary, rod genesis spans a broader temporal window that overlaps with the birth of all other neuronsfrom E12 to postnatal day 8 (P8) -but a majority of rods are born postnatally (P0-P2) (9) (10) (11) .
The early-born (prenatal) rods are present primarily in the inner side of ONL and have certain characteristics distinct from the late-born (postnatal) rods (12) . Post-mitotic photoreceptor precursors, in both rodents and primates, exhibit variable delays before expressing their respective opsin photopigments (12, 13) .
We undertook this study to elucidate molecular mechanism(s) of enhanced S-cone function in the rd7 mouse and ESCS patients. Here, we report that additional S-cones in the rd7 mouse retina originate from the post-mitotic early-born photoreceptor precursors that are committed to rod fate and not by proliferation of cone photoreceptors. Our data suggest distinct roles of NRL and NR2E3 in establishing rod identity during retinal differentiation, provide strong evidence for S-cone being the "default" fate of mammalian photoreceptor precursors, and reveal insights into possible mechanism of retinal disease caused by NR2E3 mutations.
RESULTS

Loss of Nr2e3 function leads to expression of cone-specific genes in rod precursors
To investigate the origin of increased S-cones in rd7 retina, we generated the Nrl::GFP/rd7 mice by breeding the rd7 mouse with the Nrl::GFP/WT transgenic line, where developing and mature rods are tagged with GFP expressed under the control of mouse Nrl promoter (10) . Immunohistochemistry with anti-S-opsin antibody revealed positive staining primarily in the ventral retina at different developmental stages that were examined, and more Sopsin (+) cells were detected in Nrl::GFP/rd7 retina than in Nrl::GFP/WT retina (Fig. 1A, B, showing data at P21). The S-opsin and GFP signals co-localized in the Nrl::GFP/rd7 but not in Nrl::GFP/WT retina. Cell counting revealed co-labeling of 60-70% of the S-opsin positive cells with GFP in the Nrl::GFP/rd7 retina. However, in P28 rd7 retina, GFP signal was weaker and detectable in fewer S-opsin(+) cells that were present primarily in the middle or inner part of ONL (data not shown). Similar results were obtained with the Nrl -/-retina, where GFP expression decreased at P28 and was undetectable at later stages (data not shown).
Immunostaining of dissociated retinal cells from Nrl::GFP/rd7 mice was performed to validate the co-localization of S-opsin and GFP in photoreceptors. S-opsin and GFP were colocalized in some dissociated retinal cells from P10 Nrl::GFP/rd7 mouse ( Fig. 1C) but not from the Nrl::GFP/WT mouse (data not shown). Cell counting showed co-labeling of around 50% of the S-opsin(+) cells with GFP. S-opsin and GFP immunoreactivity are detected in the outer segments and cell bodies, respectively. Because outer segments are generally broken off from the cell bodies during dissociation and GFP signal is somewhat weaker, we weren't able to detect S-opsin and GFP co-localization in retinal photoreceptors from P28 Nrl::GFP/rd7 mice. We did not detect any precise co-localization of GFP and M-opsin in either retinal sections or dissociated retinal cells (data not shown).
We then performed quantitative RT-PCR (qPCR) assays using RNA from flow-sorted Since the Nrl promoter directed the expression of GFP to developing and mature rod photoreceptors in WT retina, co-localization of S-opsin and GFP, together with expression profiling of GFP(+) photoreceptors of Nrl::GFP/rd7 mice, indicate that some photoreceptor precursors abnormally express S-cone genes in the absence of NR2E3. These data are similar to those obtained with the Nrl -/-mice, in which all photoreceptor precursors fated to be rods are transformed into S-cones in the absence of functional NRL and NR2E3 (10) .
Excess of S-opsin expressing photoreceptors in the rd7 retina are predominantly generated from the early-born photoreceptor precursors
Why do some, but not all, GFP(+) rod cells express S-opsin in the rd7 retina? Previous thymidine birthdating studies in mice had shown that early-born rods are located in the inner and middle part of the ONL, whereas late-born rods are distributed in the outer part of the ONL (9) .
As most of the excess S-opsin(+) cells are located in the inner and middle part of the ONL in the rd7 retina, we hypothesized that these "extra S-cones" were generated from photoreceptor precursors that are supposed to produce early-born (prenatal) rods.
To examine this further, we performed birthdating studies by injecting a single dose of BrdU at E15.5 during the late phase of cone but an early stage of rod genesis, and then analyzed the retina at P21. In WT retina, most solid BrdU(+) photoreceptors localized to the inner part of the ONL and did not express S-opsin (early-born rods). Fragmented BrdU signals were observed primarily in the outer part of the ONL, indicating these photoreceptors were primarily late-born rods. A few solid BrdU(+) and S-opsin(+) photoreceptors that localized to the outer part of the ONL close to the peripheral retina, were late-born cones (Fig. 3A) , consistent with a previous report (9) . While the overall BrdU staining pattern did not change in the rd7 retina, colocalization of solid BrdU and S-opsin was observed in the inner and middle part of the ONL where rod photoreceptors are present in WT mice (Fig. 3A) . Cell counting revealed 40±5 BrdU+ cells/hpf in both rd7 and WT retina. S-opsin and BrdU did not colocalize in either WT or rd7 retina ( Figure 3C ), further confirming that only early-born rods express S-opsin in the rd7 retina.
We also performed short-term (1 hr) BrdU labeling and TUNEL staining at E16, P2, P6, and P10; no obvious differences in cell proliferation and apoptosis were observed between rd7
and WT retina (data not shown). Thus, our data show that additional S-cones in rd7 retina are generated from photoreceptor precursors fated to be rods and not by abnormal cell proliferation or selective apoptosis. These results suggest that NR2E3 is sufficient to suppress the cone genes in the photoreceptor precursors and prevent the degeneration of rods in rd7 mouse.
Ectopic expression of
Notably, oscillatory potentials (OPs) were present even at dimmer intensities in the scotopic range for the WT, rd7, and Crx::Nr2e3/rd7 mice. Although we did not filter the waveforms to extract the OPs and measure their amplitudes, we observed that the OPs were smaller in five out of six Crx::Nr2e3/rd7 mice when compared to WT mice (see Fig. 4B ). This To evaluate the genotype versus phenotype relationship, we first generated Nrl::Nr2e3 transgenic mice in the rodless Nrl -/-background, which had no Nr2e3 expression. Southern blot analysis of the Nrl::Nr2e3 transgenic mouse DNA could discriminate the endogenous Nr2e3 gene (9.0 kb band) from the transgene (a weak 8 kb and a strong 4.9 kb band) ( Fig. 5B showing the data from one founder used for breeding the Nrl::Nr2e3/rd7 mice). All seven founder mice that were examined revealed the Nr2e3 transgene DNA, transcript and protein (data not shown); four lines had higher expression level than the other three, which might reflect different transgene insertion sites. Nr2e3 mRNA peaked at P6 and then decreased after P14, while NR2E3 protein was detected at a much lower expression level in the transgenic mice compared to the WT (Fig. 5C, 5D showing the data from one founder).
Examination of the Nrl::Nr2e3/Nrl -/-retina showed whorls and rosettes (data not shown).
Only some of the photoreceptors expressed rhodopsin, and these cells also immunostained with NR2E3 antibody ( Figure 5E ) but not with S-opsin antibody ( Figure 5F ). Figure 6A ). We examined retinas from WT, rd7 and Nrl::Nr2e3/rd7 transgenic mice at P21 (data not shown). We conclude that the expression of functional NR2E3 in newborn photoreceptors is sufficient to restore the rod phenotype in rd7 mice by suppressing the abnormally expressed cone genes and activation of the rod genes.
Scotopic and photopic ERGs were also performed at 6 months of age to evaluate rod and cone photoreceptor function, respectively, in the WT (n=5), rd7 (n=4), and Nrl::Nr2e3/rd7 (n=4) mice (Fig. 6D) . The dark-adapted a-and b-wave amplitudes were reduced by about 50% at the higher intensities in rd7 mice, but they were restored to WT level in the Nrl::Nr2e3/rd7 mice. 
DISCUSSION
During retinal neurogenesis, an array of cell types are produced from multipotent neuroepithelial progenitors whose states of competence are defined by intrinsic programs and altered over time leading to restricted cell fate choice (8, 54, 55) . The data reported here, combined with previous studies, show that NRL and NR2E3 play distinct roles during rod photoreceptor differentiation. NRL first activates NR2E3 in newborn photoreceptors that are committed to a rod fate. In these early-born rods, NR2E3 suppresses the cone pathway, and together with NRL it reduces the competence of the early-born photoreceptor precursors to become functional rods only. In the absence of NR2E3, early-born rods cannot develop normally as S-cone genes (expressed as part of the "default" program) continue to be expressed.
In the late-born committed rod precursors, NRL is sufficient to activate rod differentiation but the presence of NR2E3 is necessary to completely suppress the cone genes in rod precursors.
Hence, the late-born cells may give rise to functional "hybrid" rods. The ability of NRL to drive rod photoreceptor differentiation could also be modulated by posttranslational modification such as sumoylation (56) . Indeed, NRL sumoylation appears to be necessary to fully activate NR2E3 expression in late-born photoreceptors and might also regulate the inhibition of cone genes.
Recently, sumoylation of NR2E3 was shown to be important for transcriptional suppression of cone gene expression (57) . The strength of cone gene inhibition could be explained by the presence of NRL and NR2E3 and also by the regulation of their activity by sumoylation or other posttranslational modifications. We conclude that though NRL determines the rod fate in photoreceptor precursors, a combined action of NRL and NR2E3 is essential for stabilization of the rod fate and their functional maturation.
Notably, additional S-cones in the rd7 retina maintain the normal dorsal-ventral gradient.
It would therefore appear that only some of the early-born rod precursors express S-cone genes. In fate mapping experiments, one could use a Cre or Flp strategy to permanently mark a lineage. A caveat of our approach is that the Nrl-GFP promoter may have variable expression in early stages of development; however, the rescue experiments (in Fig. 5 and 6 ) provide strong evidence that Nrl+ cells are still plastic in rd7 mouse and that Nr2e3 expression stabilizes rod fate.
Mutations in the human NR2E3 gene have been identified in ESCS patients, which show higher sensitivity to short-wavelength light and early onset rod degeneration (49) . The phenotypic findings strongly suggest developmental defects in both rod and cone photoreceptors.
Our studies provide a possible mechanism of disease pathogenesis resulting from NR2E3 mutations. We suggest that aberrant expression or loss of NR2E3 function causes de-repression of cone genes in the developing rod photoreceptors with predominantly S-cone characteristics. It should be noted that S-opsin is the first visual pigment to appear in the human fetal retina, and Scones account for over 90% of the photoreceptors at fetal week 19, with subsequent decrease in number as development proceeds (60) . We propose that many of these S-cones acquire rod phenotype upon NRL and NR2E3 expression, and that loss of functional NR2E3 does not permit complete suppression of S-cone genes leading to enhanced S-cone syndrome. Aberrant expression of cone genes in NRL-expressing rod photoreceptors would then result in cell death.
Our studies are consistent with the transcriptional dominance model (14) and support the combined role of NRL and NR2E3 in driving the rod photoreceptor fate from a postmitotic photoreceptor precursor, which otherwise would follow a "default" pathway to generate S-cones.
The model in Fig. 7 (based on the data reported here and in refs. (34, 52) ) represents the scenarios in the presence or absence of NRL or NR2E3. NRL primarily acts as an instructive factor and initiates the expression of genes that define rod morphology and function. However, NRL(+) cells stay in a reversible transition stage and maintain plasticity until NR2E3 is expressed. NR2E3, a downstream target of NRL, acts primarily to stabilize the rod fate by suppressing the cone genes in NRL-expressing photoreceptor precursors. NR2E3 is therefore a key factor for rod photoreceptor lineage restriction.
MATERIALS AND METHODS
Generation of transgenic mice.
All studies involving mice were performed in accordance with institutional and federal guidelines and approved by the University Committee on Use and Care of Animals at the University of Michigan and National Eye Institute. Nrl::GFP/rd7 mice were generated by breeding rd7 (C57BL/6) mice with Nrl::GFP/WT (C57BL/6 X SJL) mice (10) . Retinal cell dissociation and Immunocytochemistry.
Freshly dissected retina was transferred into an eppendorf tube with 500 ml of PBS.
Trypsin was added at a final concentration of 1mg/ml and incubated at 37 o C for 5 min. The mixture was triturated 3-5 times with a P1000 tip to generate a single cell suspension. Then, 50ml of horse serum was added to inhibit trypsin, followed by the addition of DNaseI (final concentration 20mg/ml). Dissociated cells were then centrifuged at 3000x g for 1 min. Cells were resuspended in PBS and fixed with 4% paraformaldehyde (PFA). Immunocytochemistry procedure was similar, except that the cells were incubated on a shaker and spun down using a centrifuge (52) .
qPCR analysis
The protocol and primers for qPCR of rod and cone genes have been described previously (10, 25, 31) . Briefly, total RNA was extracted from the freshly flow-sorted GFP+ retinal cells or whole retina using Trizol reagent (Invitrogen) and then treated with RNase-free DNase I before reverse transcription. Quantitative (real time) PCR (35 cycles) was conducted with the iCycler IQ system (BioRad, Hercules, CA). Hprt gene was used as an internal control.
BrdU birthdating.
Timed pregnant females or pups received a single intraperitoneal injection of 5-bromo-2'-deoxyuridine (BrdU, Sigma, 0.1mg/g body weight) at E15, E16, E17, P2, P6 or P10.
Pups were sacrificed after 1 hour or at 3 weeks of age. Eyes were fixed in 4% paraformaldehyde (PFA) and cryosectioned. BrdU immunohistochemistry was performed after the immunostaining with other antibodies. Sections were washed in PBTx (PBS + 0.1% Triton X100) and incubated in 2.4N HCl/PBTx at 37C for 75 min. After washing with PBTx, the sections were processed for BrdU staining (10).
Cell Counting
All eyeballs were oriented appropriately to reflect ventral to dorsal expression of S-opsin in the mouse retina, and the sections were cut through the optic nerve. The area chosen for cell counting were in the middle part of ventral retina. Three sections from three different mice were used after immunohistochemistry. The criteria for solid BrdU staining included BrdU staining outlining a nucleus shape and signal over at least 70% of nucleus. Pictures taken by 40x
objective lens (high power field) were used for quantification.
ERG Recording
ERGs were recorded as described (34, 61) . Briefly, animals were dark-adapted for 12 hours and were prepared under dim red illumination. Animals were anesthetized with a loading dose of ketamine (93 mg/Kg, IP) and xylazine (8 mg/Kg, IP). Pupils were dilated with topical 1% Atropine and 0.5% Tropicamide. Body temperature was maintained at 37°C with a heating pad. Corneal ERGs were recorded from both eyes using gold wire loops with 0.5% tetracaine topical anesthesia and a drop of 2% methylcellulose for corneal hydration. A gold wire loop placed in the mouth was used as reference, and ground electrode was on the tail.
ERGs were recorded with a Ganzfeld configuration to brief xenon white flashes (1.09 log cd-s/m 2 /flash maximum intensity). Responses were amplified at 10,000 gain at 0.1 to 1000 Hz, and digitized at a rate of 32 KHz. A notch filter was used to remove 60 Hz line noise. Scotopic
ERGs were recorded at 3 to 60 second intervals depending upon the stimulus intensity and were computer averaged. Stimulus intensity was attenuated with neutral density filters over a 6.5 log unit range. 
